Literature DB >> 22712642

TCF7L2 polymorphism and cognitive test performance in cardiovascular disease.

Therese Anne Keary1, John Gunstad, Andreana Benitez, Mary Beth Spitznagel, Jeanne McCaffery, John E McGeary, Athena Poppas, Robert H Paul, Lawrence H Sweet, Ronald A Cohen.   

Abstract

AIMS: The present study examines cognitive function among transcription factor 7-like 2 (TCF7L2) genotype groups in a sample of older adults with cardiovascular disease.
METHODS: We recruited 111 older adults with diagnosed cardiovascular disease from outpatient cardiology clinics. Neuropsychological tests assessed the following domains of cognitive functioning: global function, attention/executive/psychomotor speed, learning and memory, visuospatial/construction, motor, and language. Genotyping of TCF7L2 single nucleotide polymorphism rs7903146 was conducted to determine membership in the TT, CT, or CC genotype groups.
RESULTS: Controlling for diabetes status, participants with the TT genotype of TCF7L2 (n= 12) performed worse on tests of attention/executive function/processing speed than those with the CC (n= 46) and CT (n= 53) genotypes, despite no between-group differences in demographic or medical variables.
CONCLUSIONS: Older cardiovascular disease patients with the TCF7L2 TT genotype performed worse on tests of attention/executive/ psychomotor speed than CC and CT genotype carriers. Further work using neuroimaging and glucose tolerance indices is needed to clarify underlying mechanisms.
© 2012 The Authors. Psychogeriatrics © 2012 Japanese Psychogeriatric Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22712642      PMCID: PMC4289601          DOI: 10.1111/j.1479-8301.2011.00398.x

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  51 in total

1.  CLINICAL NEUROPSYCHOLOGY.

Authors:  H KLOVE
Journal:  Med Clin North Am       Date:  1963-11       Impact factor: 5.456

2.  Neuropsychological functioning among cardiac rehabilitation patients.

Authors:  D J Moser; R A Cohen; M M Clark; M S Aloia; B A Tate; S Stefanik; D E Forman; P L Tilkemeier
Journal:  J Cardiopulm Rehabil       Date:  1999 Mar-Apr       Impact factor: 2.081

3.  The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND).

Authors:  David L Nyenhuis; Philip B Gorelick; Emily J Geenen; Clifford A Smith; Eugenia Gencheva; Sally Freels; Leyla deToledo-Morrell
Journal:  Clin Neuropsychol       Date:  2004-02       Impact factor: 3.535

Review 4.  The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.

Authors:  Nesrine Awad; Michèle Gagnon; Claude Messier
Journal:  J Clin Exp Neuropsychol       Date:  2004-11       Impact factor: 2.475

Review 5.  Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.

Authors:  Gustavo C Román; Perminder Sachdev; Donald R Royall; Roger A Bullock; Jean-Marc Orgogozo; Secundino López-Pousa; Raul Arizaga; Anders Wallin
Journal:  J Neurol Sci       Date:  2004-11-15       Impact factor: 3.181

Review 6.  Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Authors:  Sho-ichi Yamagishi; Tsutomu Imaizumi
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

7.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women.

Authors:  K Yaffe; T Blackwell; A M Kanaya; N Davidowitz; E Barrett-Connor; K Krueger
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

8.  Psychomotor performance in elderly hypertensive patients.

Authors:  L Kalra; S H Jackson; C G Swift
Journal:  J Hum Hypertens       Date:  1993-06       Impact factor: 3.012

9.  The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia.

Authors:  Kelly Davis Garrett; Jeffrey N Browndyke; William Whelihan; Robert H Paul; Margaret DiCarlo; David J Moser; Ronald A Cohen; Brian R Ott
Journal:  Arch Clin Neuropsychol       Date:  2004-09       Impact factor: 2.813

10.  Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study.

Authors:  M E Farmer; S J Kittner; R D Abbott; M M Wolz; P A Wolf; L R White
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

View more
  1 in total

Review 1.  Genetic Variants behind Cardiovascular Diseases and Dementia.

Authors:  Wei-Min Ho; Yah-Yuan Wu; Yi-Chun Chen
Journal:  Genes (Basel)       Date:  2020-12-18       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.